Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple MyelomaRecruiting
NCT06207799Phase 2Updated Aug 10, 2026
Sponsor: M.D. Anderson Cancer Center
Multiple Myeloma · Post-transplant MRD-guided Maintenance Therapy · Pre-transplant Purging
United States
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of AgeRecruiting
NCT07730450Phase 4Updated Aug 7, 2026
Sponsor: BioNTech SE
COVID-19 Vaccines
United States
A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19Completed
NCT07222384Phase 3Updated Aug 7, 2026
Sponsor: BioNTech SE
COVID-19 · SARS-COV-2 Infection
United States, Puerto Rico
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With TucatinibNot Yet Recruiting
NCT06983691NAUpdated Aug 7, 2026
Sponsor: Duke University
HER2+ Metastatic Breast Cancer (MBC)
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)Recruiting
NCT07566156Phase 3Updated Aug 6, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Urothelial Cancer · Urinary Bladder Neoplasms
United States
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenCompleted
NCT05543616Phase 3Updated Aug 6, 2026
Sponsor: BioNTech SE
SARS-CoV-2 Virus · Severe Acute Respiratory Syndrome Coronavirus 2 · COVID-19
United States, Brazil, Mexico, Puerto Rico, South Africa
Measurable Residual Disease-Guided Post-Transplant Elranatamab MaintenanceRecruiting
NCT06483100Phase 2Updated Aug 6, 2026
Sponsor: Washington University School of Medicine
Multiple Myeloma
United States
A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male AdultsCompleted
NCT07508228Phase 1Updated Aug 6, 2026
Sponsor: Pfizer
Healthy
United States
Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell CarcinomaActive Not Recruiting
NCT04919122N/AUpdated Aug 5, 2026
Sponsor: Duke University
Metastatic Renal Cell Carcinoma
United States
Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic ArthritisRecruiting
NCT05754710N/AUpdated Aug 3, 2026
Sponsor: Pfizer
Psoriatic Arthritis, Juvenile · Polyarticular Juvenile Idiopathic Arthritis
South Korea
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative ColitisActive Not Recruiting
NCT04624230Phase 3Updated Aug 3, 2026
Sponsor: Pfizer
Ulcerative Colitis
United States, Australia, Belgium, Canada, Finland +11 more
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.Not Yet Recruiting
NCT07340619Phase 2Updated Aug 3, 2026
Sponsor: UNICANCER
Metastatic (Stage IV) Melanoma
France
Korean Post-marketing Surveillance for Xeljanz XRRecruiting
NCT04876781N/AUpdated Aug 3, 2026
Sponsor: Pfizer
Active Moderate to Severe Rheumatoid Arthritis · Active Ankylosing Spondylitis · Active Psoriatic Arthritis
South Korea
Surveillance of Non-invasive Streptococcus Pneumoniae Infections in BelgiumCompleted
NCT04447521N/AUpdated Aug 3, 2026
Sponsor: Sciensano
Pneumonia · Otitis Media · Sinusitis Bacterial
Belgium
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.Recruiting
NCT05355701Phase 1Updated Jul 31, 2026
Sponsor: Pfizer
Melanoma · Non-Small-Cell Lung Cancer · Thyroid Cancer · Glioma
United States, Canada, Israel
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal CancerActive Not Recruiting
NCT05217446Phase 2Updated Jul 31, 2026
Sponsor: Pfizer
Metastatic Colorectal Cancer
United States, Australia, Belgium, Canada, Czechia +10 more
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent MigraineActive Not Recruiting
NCT06616194Phase 3Updated Jul 30, 2026
Sponsor: Pfizer
Migraine
United States, Canada, China, Czechia, Finland +7 more
RecoverPC: Relugolix vs GnRH Agonist in Quality of LifeRecruiting
NCT05765500Phase 2Updated Jul 30, 2026
Sponsor: Dana-Farber Cancer Institute
Prostate Cancer · Prostatic Neoplasms
United States
CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)Completed
NCT01134575Phase 2Updated Jul 30, 2026
Sponsor: M.D. Anderson Cancer Center
Acute Lymphoblastic Leukemia
United States
African Cancer Genome: GMDCompleted
NCT05754658N/AUpdated Jul 30, 2026
Sponsor: Fox Chase Cancer Center
Breast Cancer · Prostate Cancer
United States
Axitinib + Ipilimumab in Advanced MelanomaActive Not Recruiting
NCT04996823Phase 2Updated Jul 30, 2026
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Melanoma
United States
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation TherapyRecruiting
NCT05327465NAUpdated Jul 29, 2026
Sponsor: Dana-Farber Cancer Institute
Androgen Deprivation Therapy · Prostate Cancer · Prostate Cancer Metastatic
United States
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With MigraineRecruiting
NCT07609914Phase 4Updated Jul 29, 2026
Sponsor: Pfizer
Acute Treatment of Migraine
United States
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia AreataNot Yet Recruiting
NCT07733765Phase 3Updated Jul 29, 2026
Sponsor: Pfizer
Alopecia Areata
United States
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsRecruiting
NCT05156398Phase 3Updated Jul 29, 2026
Sponsor: Pfizer
Migraine
United States, Canada, France, Italy, Japan +2 more

Previous page Next page